A marker-free technology for mapping the epigenome of cell types in mammalian tissues
用于绘制哺乳动物组织细胞类型表观基因组图谱的无标记技术
基本信息
- 批准号:10341084
- 负责人:
- 金额:$ 37.43万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2020
- 资助国家:美国
- 起止时间:2020-02-04 至 2025-01-31
- 项目状态:未结题
- 来源:
- 关键词:
项目摘要
PROJECT SUMMARY
The genome within cells of a multicellular organism is identical, yet distinct cell types display varied functions
due to differences in their epigenome. Therefore, mapping the genome-wide epigenetic landscape of different
cell types within a tissue is critical for understanding cell type-specific gene expression regulation. Techniques
to map epigenetic factors currently rely on our ability to isolate the desired cell types at high purity with certain
biochemical assays, such as quantifying protein-DNA contacts, also requiring a large number of starting cells.
However, cell type-specific markers and antibodies are frequently unknown or unavailable, presenting a major
challenge in isolating cell types at high purity. While transgenic animal models that express cell type-specific
fluorescent reporters can overcome this limitation in some cases, generation of these animal models is time
consuming. Further, tissues frequently contain rare cell types, making it challenging to isolate large numbers of
such cells that are required for assays mapping the binding landscape of transcription factors or chromatin
modifying proteins. To overcome limitations of these current approaches, the overall goal of this proposal is to
establish a marker-free high-throughput technology to map the epigenome of different cell types within a tissue
by developing single-cell sequencing methods to simultaneously quantify the transcriptome and epigenome from
the same cell. The single-cell transcriptomes will be used for the unbiased identification of cell types in silico,
and the corresponding epigenomes of cells belonging to the same cell type will be pooled to generate high-
quality cell type-specific epigenetic landscapes. More specifically, in Aim 1 we propose to develop a single-cell
multiomics technology to simultaneously quantify mRNA, 5mC and DNA accessibility from the same cell. Unlike
a recently developed method that makes these measurements by physically separating mRNA from genomic
DNA, our technology does not involve the physical separation of nucleic acids, thereby enabling high-throughput
processing of thousands of single cells per day. Preliminary experiments suggest that we can efficiently make
these combined measurements from the same cell. In Aim 2, we propose to develop a new single-cell method
to simultaneously quantify mRNA and protein-DNA contacts from the same cell. In preliminary experiments, we
mapped genome-nuclear lamina interactions or the binding pattern of a chromatin modifying protein together
with mRNA from the same cell. Finally, as proof-of-concept that the methods developed in this proposal can be
used to map cell type-specific epigenetic profiles from in vivo tissue samples, we will quantify methylome and
DNA accessibility patterns for cell types in the rat retina. The retina is well-studied neural tissue with over 50 cell
types, including rare ones, and therefore serves as an excellent testbed to validate our technologies. Thus,
through the development of these multiomics single-cell methods, we expect to develop a technology that can
be applied to map the epigenome of different cell types in a tissue without a priori knowledge of cell type-specific
markers, enabling deeper understanding of the mechanisms of gene regulation in heterogeneous tissues.
项目摘要
多细胞生物细胞内的基因组是相同的,但不同的细胞类型显示了多样的功能
由于其表观基因组的差异。因此,映射不同基因组的表观遗传景观
组织内的细胞类型对于理解细胞类型特异性基因表达调节至关重要。技术
为了绘制表观遗传因素,目前依赖于我们在纯度高纯度分离所需的细胞类型的能力中
生化测定,例如量化蛋白质-DNA接触,还需要大量的起始细胞。
但是,细胞类型特异性的标记和抗体通常是未知或不可用的,这是一个专业
在高纯度下隔离细胞类型方面的挑战。而表达细胞类型特异性的转基因动物模型
在某些情况下,荧光记者可以克服这一局限性,这些动物模型的产生是时间
消费。此外,组织经常包含罕见的细胞类型,使大量的细胞类型具有挑战性
测定映射转录因子或染色质的结合景观所需的细胞
修饰蛋白质。为了克服这些当前方法的局限性,该提案的总体目标是
建立无标记的高通量技术,以绘制组织中不同细胞类型的表观基因组
通过开发单细胞测序方法以同时量化转录组和表观基因组
相同的单元格。单细胞转录组将用于对硅中细胞类型的无偏鉴定,
并且属于同一细胞类型的细胞的相应表观基因组将被合并以产生高
优质细胞类型的表观遗传景观。更具体地说,在AIM 1中,我们建议开发一个单细胞
多组学技术可同时从同一细胞量化mRNA,5MC和DNA可及性。与众不同
最近开发的方法,通过将mRNA与基因组进行物理分离来进行这些测量
DNA,我们的技术不涉及核酸的物理分离,从而实现高通量
每天处理数千个单元。初步实验表明我们可以有效地进行
这些来自同一细胞的合并测量。在AIM 2中,我们建议开发一种新的单细胞方法
同时量化来自同一细胞的mRNA和蛋白-DNA接触。在初步实验中,我们
映射的基因组 - 核薄片相互作用或染色质修饰蛋白的结合模式一起
带有来自同一细胞的mRNA。最后,作为概念证明,本提案中开发的方法可以是
用于绘制体内组织样品的细胞类型特异性表观遗传谱,我们将量化甲基甲基和
大鼠视网膜中细胞类型的DNA可及性模式。视网膜是研究良好的神经组织,超过50个细胞
包括稀有类型的类型,因此是验证我们技术的出色测试。因此,
通过开发这些多域单细胞方法,我们希望开发一种可以
应用于组织中不同细胞类型的表观基因组,而没有先验的细胞类型特异性知识
标记,使能够更深入地了解异质组织基因调节的机制。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

暂无数据
数据更新时间:2024-06-01
Siddharth Subhas D...的其他基金
A marker-free technology for mapping the epigenome of cell types in mammalian tissues
用于绘制哺乳动物组织细胞类型表观基因组图谱的无标记技术
- 批准号:1056059010560590
- 财政年份:2020
- 资助金额:$ 37.43万$ 37.43万
- 项目类别:
Understanding DNA methylation reprogramming dynamics during preimplantation development using single-cell sequencing
使用单细胞测序了解植入前发育过程中的 DNA 甲基化重编程动态
- 批准号:1020891910208919
- 财政年份:2019
- 资助金额:$ 37.43万$ 37.43万
- 项目类别:
Understanding DNA methylation reprogramming dynamics during preimplantation development using single-cell sequencing
使用单细胞测序了解植入前发育过程中的 DNA 甲基化重编程动态
- 批准号:98033389803338
- 财政年份:2019
- 资助金额:$ 37.43万$ 37.43万
- 项目类别:
Understanding DNA methylation reprogramming dynamics during preimplantation development using single-cell sequencing
使用单细胞测序了解植入前发育过程中的 DNA 甲基化重编程动态
- 批准号:1043019710430197
- 财政年份:2019
- 资助金额:$ 37.43万$ 37.43万
- 项目类别:
Understanding DNA methylation reprogramming dynamics during preimplantation development using single-cell sequencing
使用单细胞测序了解植入前发育过程中的 DNA 甲基化重编程动态
- 批准号:1001806410018064
- 财政年份:2019
- 资助金额:$ 37.43万$ 37.43万
- 项目类别:
Understanding DNA methylation reprogramming dynamics during preimplantation development using single-cell sequencing
使用单细胞测序了解植入前发育过程中的 DNA 甲基化重编程动态
- 批准号:1065181810651818
- 财政年份:2019
- 资助金额:$ 37.43万$ 37.43万
- 项目类别:
相似国自然基金
温度作用下CA砂浆非线性老化蠕变性能的多尺度研究
- 批准号:12302265
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
基于波动法的叠层橡胶隔震支座老化损伤原位检测及精确评估方法研究
- 批准号:52308322
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
微纳核壳结构填充体系构建及其对聚乳酸阻燃、抗老化、降解和循环的作用机制
- 批准号:52373051
- 批准年份:2023
- 资助金额:50 万元
- 项目类别:面上项目
东北黑土中农膜源微塑料冻融老化特征及其毒性效应
- 批准号:42377282
- 批准年份:2023
- 资助金额:49 万元
- 项目类别:面上项目
高层建筑外墙保温材料环境暴露自然老化后飞火点燃机理及模型研究
- 批准号:52376132
- 批准年份:2023
- 资助金额:50 万元
- 项目类别:面上项目
相似海外基金
The Role of Glycosyl Ceramides in Heart Failure and Recovery
糖基神经酰胺在心力衰竭和恢复中的作用
- 批准号:1064487410644874
- 财政年份:2023
- 资助金额:$ 37.43万$ 37.43万
- 项目类别:
Promoting regenerative repair of aged cartilage
促进老化软骨的再生修复
- 批准号:1066018410660184
- 财政年份:2023
- 资助金额:$ 37.43万$ 37.43万
- 项目类别:
Identifying epigenetic factors in control of epidermal stem cell longevity in the adult skin
识别控制成人皮肤表皮干细胞寿命的表观遗传因素
- 批准号:1072321210723212
- 财政年份:2023
- 资助金额:$ 37.43万$ 37.43万
- 项目类别:
PET tracer for imaging senescence
用于衰老成像的 PET 示踪剂
- 批准号:1072782310727823
- 财政年份:2023
- 资助金额:$ 37.43万$ 37.43万
- 项目类别:
Optimizing integration of veterinary clinical research findings with human health systems to improve strategies for early detection and intervention
优化兽医临床研究结果与人类健康系统的整合,以改进早期检测和干预策略
- 批准号:1076445610764456
- 财政年份:2023
- 资助金额:$ 37.43万$ 37.43万
- 项目类别: